Skip to main content
AUPH
NASDAQ Life Sciences

Aurinia Q2 Revenue Jumps 19% to $83.2M, EPS Soars 75% to $0.28; Guidance Reiterated

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$15.75
Mkt Cap
$1.953B
52W Low
$10.34
52W High
$19.25
52W Position info
52% above low
Off High info
18% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

AUPH sits 52% above its 52-week low of $10.34.

Summary

Aurinia delivered strong Q2 results with LUPKYNIS net product sales up 19% to $79.4M, driving total revenue to $83.2M. Net income surged 74% to $37.4M, and diluted EPS hit $0.28, a 75% increase. The company generated $52.5M in operating cash flow and ended the quarter with $443.1M in cash, after repurchasing 5M shares for $74.9M. Full-year guidance was reiterated at $315M-$325M in total revenue, signaling confidence in continued growth. The launch of the PRESERVE Phase 4 study and advancement of aritinercept into four indications highlight pipeline momentum. This follows the Kezar acquisition and positive LUPKYNIS data in June, reinforcing a strong operational trajectory.

At the time of this announcement, AUPH was trading at $15.75 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2B. The 52-week trading range was $10.34 to $19.25. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

AUPH - Latest Insights

AUPH
Oct 30, 2026, 8:07 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $16.62
Real-time Price: $15.34 info
Change: -$1.28 (-8%) info
Market Cap: $2.064B info
AUPH
Oct 30, 2026, 8:00 AM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $17.21
Real-time Price: $15.34 info
Change: -$1.87 (-11%) info
Market Cap: $2.064B info
AUPH
Aug 19, 2026, 4:11 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $16.34
Real-time Price: $15.34 info
Change: -$1.00 (-6%) info
Market Cap: $2.064B info
AUPH
Aug 19, 2026, 4:07 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $16.57
Real-time Price: $15.34 info
Change: -$1.23 (-7%) info
Market Cap: $2.064B info
AUPH
Aug 06, 2026, 8:16 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $15.75
Real-time Price: $15.34 info
Change: -$0.411 (-3%) info
Market Cap: $2.064B info